SJOGREN SYNDROME
Clinical trials for SJOGREN SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SJOGREN SYNDROME trials appear
Sign up with your email to follow new studies for SJOGREN SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to tame autoimmune attack in Sjogren's patients
Disease control OngoingThis study is testing whether a new drug called ianalumab can reduce disease activity and symptoms in people with active Sjogren's syndrome. About 276 participants will receive either the drug or a placebo as a monthly injection for nearly a year. Researchers will measure changes…
Matched conditions: SJOGREN SYNDROME
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug trial aims to tame debilitating autoimmune disease
Disease control OngoingThis large, late-stage study is testing whether a new drug called ianalumab can help control the disease and reduce symptoms for people with active Sjogren's syndrome. About 500 participants will receive injections of either the drug or a placebo for nearly a year to see if it sa…
Matched conditions: SJOGREN SYNDROME
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Tracking High-Risk pregnancies to unlock better care for women with rare diseases
Knowledge-focused TerminatedThis study aimed to gather information about pregnancy in women with rare autoimmune diseases like lupus and rheumatoid arthritis. Researchers planned to follow these pregnancies to understand complications and how medications affect both mother and baby. The goal was to use this…
Matched conditions: SJOGREN SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC